These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

420 related items for PubMed ID: 29203513

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Regulation of osteoclast differentiation by fibroblast growth factor 2: stimulation of receptor activator of nuclear factor kappaB ligand/osteoclast differentiation factor expression in osteoblasts and inhibition of macrophage colony-stimulating factor function in osteoclast precursors.
    Chikazu D, Katagiri M, Ogasawara T, Ogata N, Shimoaka T, Takato T, Nakamura K, Kawaguchi H.
    J Bone Miner Res; 2001 Nov; 16(11):2074-81. PubMed ID: 11697804
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. The differential expression of osteoprotegerin (OPG) and receptor activator of nuclear factor kappaB ligand (RANKL) in human osteoarthritic subchondral bone osteoblasts is an indicator of the metabolic state of these disease cells.
    Kwan Tat S, Pelletier JP, Lajeunesse D, Fahmi H, Lavigne M, Martel-Pelletier J.
    Clin Exp Rheumatol; 2008 Nov; 26(2):295-304. PubMed ID: 18565252
    [Abstract] [Full Text] [Related]

  • 28. Secreted frizzled-related protein-1 inhibits RANKL-dependent osteoclast formation.
    Häusler KD, Horwood NJ, Chuman Y, Fisher JL, Ellis J, Martin TJ, Rubin JS, Gillespie MT.
    J Bone Miner Res; 2004 Nov; 19(11):1873-81. PubMed ID: 15476588
    [Abstract] [Full Text] [Related]

  • 29. Bradykinin potentiates cytokine-induced prostaglandin biosynthesis in osteoblasts by enhanced expression of cyclooxygenase 2, resulting in increased RANKL expression.
    Brechter AB, Lerner UH.
    Arthritis Rheum; 2007 Mar; 56(3):910-23. PubMed ID: 17328065
    [Abstract] [Full Text] [Related]

  • 30. Protein expression and functional difference of membrane-bound and soluble receptor activator of NF-kappaB ligand: modulation of the expression by osteotropic factors and cytokines.
    Nakashima T, Kobayashi Y, Yamasaki S, Kawakami A, Eguchi K, Sasaki H, Sakai H.
    Biochem Biophys Res Commun; 2000 Sep 07; 275(3):768-75. PubMed ID: 10973797
    [Abstract] [Full Text] [Related]

  • 31. Zebrafish scales respond differently to in vitro dynamic and static acceleration: analysis of interaction between osteoblasts and osteoclasts.
    Kitamura K, Takahira K, Inari M, Satoh Y, Hayakawa K, Tabuchi Y, Ogai K, Nishiuchi T, Kondo T, Mikuni-Takagaki Y, Chen W, Hattori A, Suzuki N.
    Comp Biochem Physiol A Mol Integr Physiol; 2013 Sep 07; 166(1):74-80. PubMed ID: 23632157
    [Abstract] [Full Text] [Related]

  • 32. Human trabecular bone-derived osteoblasts support human osteoclast formation in vitro in a defined, serum-free medium.
    Atkins GJ, Kostakis P, Welldon KJ, Vincent C, Findlay DM, Zannettino AC.
    J Cell Physiol; 2005 Jun 07; 203(3):573-82. PubMed ID: 15573398
    [Abstract] [Full Text] [Related]

  • 33. Direct crosstalk between cancer and osteoblast lineage cells fuels metastatic growth in bone via auto-amplification of IL-6 and RANKL signaling pathways.
    Zheng Y, Chow SO, Boernert K, Basel D, Mikuscheva A, Kim S, Fong-Yee C, Trivedi T, Buttgereit F, Sutherland RL, Dunstan CR, Zhou H, Seibel MJ.
    J Bone Miner Res; 2014 Sep 07; 29(9):1938-49. PubMed ID: 24676805
    [Abstract] [Full Text] [Related]

  • 34. [The participation of RANK, RANKL and OPG in tumor osteolysis].
    Stanisławowski M, Kmieć Z.
    Postepy Hig Med Dosw (Online); 2009 May 15; 63():234-41. PubMed ID: 19502684
    [Abstract] [Full Text] [Related]

  • 35. Receptor activator of nuclear factor-κB ligand (RANKL)/RANK/osteoprotegerin system in bone and other tissues (review).
    Liu W, Zhang X.
    Mol Med Rep; 2015 May 15; 11(5):3212-8. PubMed ID: 25572286
    [Abstract] [Full Text] [Related]

  • 36. Metformin stimulates osteoprotegerin and reduces RANKL expression in osteoblasts and ovariectomized rats.
    Mai QG, Zhang ZM, Xu S, Lu M, Zhou RP, Zhao L, Jia CH, Wen ZH, Jin DD, Bai XC.
    J Cell Biochem; 2011 Oct 15; 112(10):2902-9. PubMed ID: 21618594
    [Abstract] [Full Text] [Related]

  • 37. Thrombin receptor deficiency leads to a high bone mass phenotype by decreasing the RANKL/OPG ratio.
    Tudpor K, van der Eerden BC, Jongwattanapisan P, Roelofs JJ, van Leeuwen JP, Bindels RJ, Hoenderop JG.
    Bone; 2015 Mar 15; 72():14-22. PubMed ID: 25460576
    [Abstract] [Full Text] [Related]

  • 38. PIAS3 negatively regulates RANKL-mediated osteoclastogenesis directly in osteoclast precursors and indirectly via osteoblasts.
    Hikata T, Takaishi H, Takito J, Hakozaki A, Furukawa M, Uchikawa S, Kimura T, Okada Y, Matsumoto M, Yoshimura A, Nishimura R, Reddy SV, Asahara H, Toyama Y.
    Blood; 2009 Mar 05; 113(10):2202-12. PubMed ID: 18952894
    [Abstract] [Full Text] [Related]

  • 39. Receptor activator of NF-kappaB ligand induces the expression of carbonic anhydrase II, cathepsin K, and matrix metalloproteinase-9 in osteoclast precursor RAW264.7 cells.
    Fujisaki K, Tanabe N, Suzuki N, Kawato T, Takeichi O, Tsuzukibashi O, Makimura M, Ito K, Maeno M.
    Life Sci; 2007 Mar 13; 80(14):1311-8. PubMed ID: 17306833
    [Abstract] [Full Text] [Related]

  • 40. [Mechanisms of icariin in regulating bone formation of osteoblasts and bone resorption of osteoclasts].
    Ma XN, Ge BF, Chen KM, Zhou J, Shi WG, Xie YF, Guo XY, Lv X, Cheng K, Gao YH.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2013 Aug 13; 35(4):432-8. PubMed ID: 23987492
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.